首页> 外文期刊>Journal of Advanced Research >Dexamethasone abrogates the antimicrobial and antibiofilm activities of different drugs against clinical isolates of Staphylococcus aureus and Pseudomonas aeruginosa
【24h】

Dexamethasone abrogates the antimicrobial and antibiofilm activities of different drugs against clinical isolates of Staphylococcus aureus and Pseudomonas aeruginosa

机译:地塞米松消除了不同药物对金黄色葡萄球菌和铜绿假单胞菌临床分离株的抗菌和抗生物膜活性

获取原文
       

摘要

Staphylococcus aureus and Pseudomonas aeruginosa are part of the human microbiota and are also important bacterial pathogens, for which therapeutic options are lacking nowadays. The combined administration of corticosteroids and antimicrobials is commonly used in the treatment of infectious diseases to control inflammatory processes and to minimize potential toxicity of antimicrobials, avoiding sequelae. Although different pharmaceutical dosage forms of antimicrobials combined to corticosteroids are available, studies on the interference of corticosteroids on the pharmacological activity of antimicrobials are scarce and controversial. Here, we provide evidence of the interference of dexamethasone on the pharmacological activity of clinically important antimicrobial drugs against biofilms and planktonic cells of S. aureus and P. aeruginosa. Broth microdilution assays of minimal inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and minimum biofilm eradication concentration (MBEC) of gentamicin, chloramphenicol, oxacillin, ceftriaxone and meropenem were conducted with and without the addition of dexamethasone. The effect of all drugs was abrogated by dexamethasone in their MIC, MBC, and MBEC, except gentamicin and meropenem, for which the MBC was not affected in some strains. The present study opens doors for more investigations on in vitro and in vivo effects and safety of the combination of antimicrobials and glucocorticoids.
机译:金黄色葡萄球菌和铜绿假单胞菌是人类微生物群的一部分,也是重要的细菌病原体,目前缺乏治疗选择。皮质类固醇和抗菌素的联合给药通常用于治疗传染病,以控制炎症过程并使抗菌素的潜在毒性降至最低,从而避免后遗症。尽管可获得与糖皮质激素组合的抗微生物剂的不同药物剂型,但是关于糖皮质激素对抗微生物剂的药理活性的干扰的研究却很少且有争议。在这里,我们提供地塞米松对临床上重要的抗菌药物对金黄色葡萄球菌和铜绿假单胞菌生物膜和浮游细胞的药理活性的干扰的证据。在添加或不添加地塞米松的情况下,进行庆大霉素,氯霉素,奥沙西林,头孢曲松和美洛培南的最低抑菌浓度(MIC),最低杀菌浓度(MBC)和最低生物膜清除浓度(MBEC)的肉汤微稀释测定。除庆大霉素和美罗培南外,地塞米松在其MIC,MBC和MBEC中消除了所有药物的作用,但庆大霉素和美罗培南对某些菌株而言MBC不受影响。本研究为抗菌素和糖皮质激素组合的体外和体内作用及安全性的更多研究打开了大门。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号